Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
suPAR as a prognostic biomarker in critically ill patients — Katia Donadello (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
suPAR as a prognostic biomarker in critically ill patients
Shared by
Jean Louis Vincent
Université Libre de Bruxelles
suPAR as a prognostic biomarker in critically ill patients
Article
2013
en
Authors
+6 more
KD
Katia Donadello
SS
Sabino Scolletta
FT
FS Taccone
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2012
suPAR as a prognostic biomarker in sepsis
Katia Donadello
,
Sabino Scolletta
,
Cecilia Covajes
,
Jean Louis Vincent
Article
2013
Soluble urokinase–type plasminogen activator receptor as a prognostic biomarker in critically ill patients
Katia Donadello
,
Sabino Scolletta
,
Fabio Silvio Taccone
,
Cecilia Covajes
,
Cristina Santonocito
,
Diego Orbegozo Cortés
,
Daiva Gražulytė
,
Leonardo Gottin
,
Jean Louis Vincent
Article
2018
High mobility group box 1 as a biomarker in critically ill patients
Eray Yagmur
,
Lukas Buendgens
,
Ulf Herbers
,
Anne Beeretz
,
Ralf Weiskirchen
,
Ger H. Koek
,
Christian Trautwein
,
Frank Tacke
,
Alexander Koch
Article
2018
Clinical relevance of copeptin plasma levels as a biomarker of disease severity and mortality in critically ill patients
Alexander Koch
,
Eray Yagmur
,
Alexander Hoss
,
Lukas Buendgens
,
Ulf Herbers
,
Ralf Weiskirchen
,
Ger H. Koek
,
Christian Trautwein
,
Frank Tacke
Article
2016
[Hypophosphatemia in critically ill patients].
T Nguyen
,
Jean Louis Vincent
Discussion(0)
No comments yet. Be the first to comment.